Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AIM WINNERS & LOSERS: Cerillion jumps; Surgical Innovations loses CFO

8th Jan 2026 10:54

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.

----------

AIM - WINNERS

----------

Cerillion PLC, up 10% at 1,356.51 pence, 12-month range 1,950.00p-1,170.00p. The London-based billing, charging and customer relationship management software firm wins its "largest ever" contract, worth GBP42.5 million, with Oman Telecommunications. The company says Omantel is Oman's first integrated telecommunications services provider. Cerillion says the contract win helps to underpin existing market forecasts for financial 2026 and beyond. It will supply and install its BSS/OSS suite and provide ongoing support and maintenance over the five-year subscription term. Cerillion says it was selected after an extensive tender process. "We are delighted to be partnering with Omantel at this exciting time and believe that our selection is testimony to the strength of our offering and services," says Chief Executive Officer Louis Hall.

----------

Quartix Technologies PLC, up 5.3% at 300.00p, 12-month range 322.90p-147.75p. The vehicle tracking software firm expects revenue and adjusted earnings before interest, tax, depreciation and amortisation to be ahead of current market expectations for 2025. It puts 2025 expectations at revenue of GBP36.2 million and adjusted Ebitda of GBP7.7 million. The firm expects free cashflow of GBP5.1 million, despite outflows for the 4G upgrade programme in France, restructuring costs in the first half of the year and a further pre-payment of GBP700,000 in corporation tax made in December. It intends to consolidate its separate ordinary and supplementary dividends into a single ordinary dividend. Quartix expects to pay a final dividend of 7.5p, giving a total ordinary dividend for the year of 10p per share. "We are delighted with the progress made in 2025: [annualised recurring revenue] growth increased by a record GBP4.5m to GBP37m. This is significantly ahead of our expectations at the beginning of the year and stands us in excellent stead for further revenue growth in 2026," says Executive Chair Andy Walters.

----------

AIM - LOSERS

----------

ECR Minerals PLC, down 18% at 0.28p, 12-month range 0.39p-0.16p. The Australia-focused gold exploration and development company conditionally raises GBP1.5 million, before expenses, via a placing of 576.9 million new shares at 0.26p each. ECR says the fundraising marks an "important milestone" and provides the capital strength to accelerate its production and exploration strategy across Queensland and Victoria, Australia. The board says it is now positioned to transition into a multi-project gold producer and explorer. "Today's GBP1.5 million fundraising is a major step forward for ECR and we are delighted by the backing received from institutional investors. This support reflects confidence in both our strategy and our progress as we establish ECR as a multi-site gold company," says Chair Nick Tulloch.

----------

Surgical Innovations Group PLC, down 7.8% at 0.42p, 12-month range 0.75p-0.33p. The surgical and medical instrument manufacturer says Chief Financial Officer Brent Greetham told the board on Wednesday that he intends to leave the firm to "pursue other interests". The firm says the process to appoint a new CFO is underway, while Greetham will work with the group during his six months' notice period to "ensure an orderly handover". Surgical Innovations says CEO David Marsh and Non-Executive Director Andrew Boteler will "provide additional support to the finance function as required". Greetham took over as CFO in February last year, after the departure of Chris Martin to "pursue another opportunity". "As we look to the year ahead, we remain confident of the opportunities available, of how our reposable technology resonates with the market and the overall prospects of the group," says CEO Marsh.

----------

By Michael Hennessey, Alliance News reporter

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

CerillionQuartix TechECR MineralsSurgical Innovations
FTSE 100 Latest
Value10,044.69
Change0.00